FDMT (FDMT) Stock Price & Analysis
FDMT (FDMT) rose 1.84% to USD 14.97 as of September 8, 2026 at 04:15 UTC, according to Nexqual real-time market data.
FDMT last closed at USD 14.97; the session ranged USD 14.33–15 on volume of 420,636 shares. Market capitalization is —, with a 52-week range of USD 6.47–16.93 (NMS). Source: Nexqual, September 8, 2026 at 04:15 UTC.
Key Statistics (as of September 8, 2026 at 04:15 UTC)
| Price | USD 14.97 |
|---|---|
| Change | ▲ 1.84% (up) |
| Previous Close | USD 14.97 |
| Open | USD 14.97 |
| Day Range | USD 14.33 – 15 |
| 52-Week Range | USD 6.47 – 16.93 |
| Volume | 420,636 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (FDMT)
Nexqual's technical model rates FDMT "STRONG BUY" based on 5 bullish and 0 bearish signals across 128 daily candles, as of September 8, 2026 at 04:15 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 59.38 (neutral) |
| vs SMA50 | Above (USD 12.5) |
| MACD | 0.86 (positive) |
From FDMT's Latest SEC 10-K Filing (filed 2026-03-18)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| STOK | Stoke Therapeutics, Inc. | USD 29.81 | ▼ 2.26% |
| NKTX | Nkarta, Inc. | USD 2.92 | ▲ 5.61% |
| ANNX | Annexon, Inc. | USD 4.87 | ▼ 1.22% |
| ALXO | ALX Oncology Holdings Inc. | USD 2.01 | ▼ 3.37% |
| CGEM | Cullinan Therapeutics, Inc. | USD 22.09 | ▼ 1.07% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 04:15 UTC. This page is informational and not investment advice.